Market Cap 37.32B
Revenue (ttm) 4.69B
Net Income (ttm) 1.02B
EPS (ttm) N/A
PE Ratio 27.94
Forward PE 26.75
Profit Margin 21.79%
Debt to Equity Ratio 0.12
Volume 994,000
Avg Vol 975,512
Day's Range N/A - N/A
Shares Out 146.63M
Stochastic %K 89%
Beta 0.78
Analysts Sell
Price Target $258.75

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposab...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 858-836-5000
Address:
9001 Spectrum Center Boulevard, San Diego, United States
abc3000
abc3000 Jun. 18 at 1:53 PM
$IXHL Putting a high ranking member from $RMD onto Incannex's board tells me it is all the more likely that $RMD will ultimately swoop down and buy this biotech once the RePOSA Phase 2 data come out in July. 1/8 of the world's adults suffer from sleep apnea, and there is currently NO pharmacologic treatment available. This could be monumental. Plus -- I cannot wait to be one of their first customers. I HATE my sleep apnea!
0 · Reply
abc3000
abc3000 Jun. 18 at 1:24 PM
$IXHL I am going to make a prediction right now: Resmed ($RMD) is going to swoop down and buy this company once the Phase 2 RePOSA data is published.
0 · Reply
TheGiantKiller
TheGiantKiller Jun. 13 at 10:47 PM
$IXHL ResMed's ($RMD) interest in Incannex's IHL-42X for Obstructive Sleep Apnea relates to the possibility of combination therapies between IHL-42X and ResMed CRAP machines. That's the reason ResMed placed one of its scientists on the Incannex Scientific Advisory Board. There's a very good chance ResMed will make an investment in Incannex if the IHL-42X Phase 2 results come in positive.
0 · Reply
MikiTrader
MikiTrader Jun. 10 at 12:56 PM
$IXHL asked AI what I was curious about. I felt a huge flow. It's also important to note that while non-orphan drugs that qualify as New Chemical Entities (NCEs) typically benefit from 5 years of data exclusivity under the Hatch-Waxman Act. Let me explain how I feel right now... I remember when Thor got hit by the Destroyer and rolled around on the ground, Loki was thrilled but Odin was crying. I don't know if IXHL can be compared to Thor, but won't this company find its original value? Personally, I think that $1, $2, $5, etc. are all gimmicks. NFA. $KLTO $DRUG $SLNO $AMAM $IMGN $REGN $NVAX $VKTX $PFE $LLY $RMD $INSP $PHG
0 · Reply
InLongtoRetire
InLongtoRetire Jun. 6 at 7:16 PM
$RMD Almost time to acquire RemSleep Holdings.
0 · Reply
Bongasaurus
Bongasaurus Jun. 6 at 12:49 PM
$RMD go the fk back down haha. My 250ps gotta print!
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:53 PM
$RMD plummeting at close $SPY $QQQ
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:32 PM
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:11 PM
$RMD kill it! $SPY
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 6:18 PM
$RMD breaking down BIG time.. sub $250 soon. @SPY @QQQ
0 · Reply
Latest News on RMD
ResMed: A Sleeping Giant Hiding In Plain Sight

Jun 9, 2025, 5:38 AM EDT - 16 days ago

ResMed: A Sleeping Giant Hiding In Plain Sight


Top 15 High-Growth Dividend Stocks For June 2025

Jun 2, 2025, 10:00 AM EDT - 22 days ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR


Resmed Acquires VirtuOx

May 1, 2025, 9:00 AM EDT - 7 weeks ago

Resmed Acquires VirtuOx


ResMed: Cornering The Market In Sleep Solutions

Apr 24, 2025, 5:12 AM EDT - 2 months ago

ResMed: Cornering The Market In Sleep Solutions


ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 7:16 PM EDT - 2 months ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript


Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 21, 2025, 5:00 PM EDT - 2 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer


Jan De Witte joins GHO Capital as Operating Partner

Feb 11, 2025, 4:30 AM EST - 4 months ago

Jan De Witte joins GHO Capital as Operating Partner

IART


Stock Of The Day: Trading The Range In ResMed

Feb 3, 2025, 12:59 PM EST - 5 months ago

Stock Of The Day: Trading The Range In ResMed


ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 9:10 PM EST - 5 months ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript


ResMed CEO On Earnings, Sleep Apnea

Oct 29, 2024, 11:23 AM EDT - 8 months ago

ResMed CEO On Earnings, Sleep Apnea


ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript

Oct 24, 2024, 11:14 PM EDT - 8 months ago

ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript


My Top 15 High Growth Dividend Stocks For October 2024

Oct 3, 2024, 12:04 PM EDT - 9 months ago

My Top 15 High Growth Dividend Stocks For October 2024

ACN APH DPZ ELV GPN INTU MA


Why ResMed's Rally Is Just Getting Started

Sep 18, 2024, 11:30 AM EDT - 9 months ago

Why ResMed's Rally Is Just Getting Started


abc3000
abc3000 Jun. 18 at 1:53 PM
$IXHL Putting a high ranking member from $RMD onto Incannex's board tells me it is all the more likely that $RMD will ultimately swoop down and buy this biotech once the RePOSA Phase 2 data come out in July. 1/8 of the world's adults suffer from sleep apnea, and there is currently NO pharmacologic treatment available. This could be monumental. Plus -- I cannot wait to be one of their first customers. I HATE my sleep apnea!
0 · Reply
abc3000
abc3000 Jun. 18 at 1:24 PM
$IXHL I am going to make a prediction right now: Resmed ($RMD) is going to swoop down and buy this company once the Phase 2 RePOSA data is published.
0 · Reply
TheGiantKiller
TheGiantKiller Jun. 13 at 10:47 PM
$IXHL ResMed's ($RMD) interest in Incannex's IHL-42X for Obstructive Sleep Apnea relates to the possibility of combination therapies between IHL-42X and ResMed CRAP machines. That's the reason ResMed placed one of its scientists on the Incannex Scientific Advisory Board. There's a very good chance ResMed will make an investment in Incannex if the IHL-42X Phase 2 results come in positive.
0 · Reply
MikiTrader
MikiTrader Jun. 10 at 12:56 PM
$IXHL asked AI what I was curious about. I felt a huge flow. It's also important to note that while non-orphan drugs that qualify as New Chemical Entities (NCEs) typically benefit from 5 years of data exclusivity under the Hatch-Waxman Act. Let me explain how I feel right now... I remember when Thor got hit by the Destroyer and rolled around on the ground, Loki was thrilled but Odin was crying. I don't know if IXHL can be compared to Thor, but won't this company find its original value? Personally, I think that $1, $2, $5, etc. are all gimmicks. NFA. $KLTO $DRUG $SLNO $AMAM $IMGN $REGN $NVAX $VKTX $PFE $LLY $RMD $INSP $PHG
0 · Reply
InLongtoRetire
InLongtoRetire Jun. 6 at 7:16 PM
$RMD Almost time to acquire RemSleep Holdings.
0 · Reply
Bongasaurus
Bongasaurus Jun. 6 at 12:49 PM
$RMD go the fk back down haha. My 250ps gotta print!
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:53 PM
$RMD plummeting at close $SPY $QQQ
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:32 PM
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 7:11 PM
$RMD kill it! $SPY
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 6:18 PM
$RMD breaking down BIG time.. sub $250 soon. @SPY @QQQ
0 · Reply
TheProfitPhantom
TheProfitPhantom Jun. 5 at 3:45 PM
$RMD short til $148 IMO $SPY $QQQ
0 · Reply
Doozio
Doozio Jun. 4 at 12:48 PM
$RMD out of 🐑⏰♾️ find the eps gap n goes on 4/24 above the 200d then it’s all chop chop huckleberries n PEGA da greed during 🐒🍌🧠⏰♾️
0 · Reply
DRex99
DRex99 May. 29 at 9:15 PM
$RMSL If Tom’s product is as good as he says it is you have to assume the big dogs are going to step in. If I’m $RMD or any major player I’m doing everything I can to slow him down. You have to assume there is going to be a fight. Competitors don’t just give up market share. Eyes open.
2 · Reply
SwingTradingPro
SwingTradingPro May. 28 at 11:59 AM
$IXHL company seems to be quite confident about phase 2 data and committed to preserve and improve shareholders value.. BO is coming sooner than later... $RMD
0 · Reply
SwingTradingPro
SwingTradingPro May. 27 at 4:27 PM
$IXHL selling for pennies will regret big time here..hold and sell above dollar.. OSA market is quite huge and $RMD is behind this drug combination...BO is in the play ..
0 · Reply
Upsidedownterry
Upsidedownterry May. 21 at 9:01 PM
$VVOS the easy exit for Seneca is to facilitate selling Vivos to Resmed $RMD , CPAP giant valued at 36 Billion or inspire medical system $INSP, valued at 4.3 Billion. Stop worrying about Dollars and Pennies, wait for the 100s of millions reward. The new buying out sleep center model improve profit per patient from $4000 to $7000, and Seneca supports this move. Vivos treatment has the lowest life time cost for patient, a big incentive for insurance company to cover patient’s out of pocket cost. This is a business even an idiot can run profitably. Buy, wait, and be rewarded handsomely
1 · Reply
trading_momentum
trading_momentum May. 21 at 1:28 PM
Put opportunity in $RMD
0 · Reply
omiabtrades
omiabtrades May. 21 at 11:21 AM
Put opportunity in $RMD
0 · Reply
mikesterz7
mikesterz7 May. 20 at 8:57 PM
$RMD Analysts expect a negative impact on ResMed Inc. after privately held pharmaceutical company and rival Apnimed, Inc. announced positive results from its late-stage clinical trial evaluating the efficacy of its lead candidate AD109 in treating obstructive sleep apnea.
0 · Reply
StocktwitsNews
StocktwitsNews May. 20 at 6:56 PM
ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved $RMD $VTI $VOO https://stocktwits.com/news/equity/markets/analysts-expect-negative-impact-resmed-from-rival-sleep-apnea-drug/ch03ELHRboq
0 · Reply
SwingTradingPro
SwingTradingPro May. 20 at 2:32 PM
$IXHL release the BO news already $RMD
1 · Reply
ridleyfw
ridleyfw May. 20 at 12:51 PM
$IXHL Patience. Too many catalysts to keep this down, including todays news, top line data , possible BO by $RMD
0 · Reply